chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: Have a throbbing HA starting day three after vaccine to present time; This is a spontaneous report from a contactable pharmacist, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6199) via an unspecified route of administration in the left arm on 07Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as N/A. The patient had known allergies to penicillin and mushrooms. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included CIALIS, METFORMIN, and PROTONIX, all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 14Feb2021 at 10:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 09Mar2021 at 08:00, the patient had a throbbing headache (HA) starting day three after vaccine to present time. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with NAPROXEN (MANUFACTURER UNKNOWN) 550 one tablet twice a day (bid). Since the vaccination, the patient had been tested for COVID-19. On 10Mar2021, the patient underwent COVID-19 test (reported as care) via nasal swab and the result was negative. The clinical outcome of the event have a throbbing HA starting day three after vaccine to present time was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival swelling, Lymph node pain, Mouth ulceration, Oropharyngeal pain
Clinical narrative: Persistent mouth ulcers; swollen gums; lymph node pain in neck; throat pain; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 26Feb2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 05Feb2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 01Mar2021, the patient experienced persistent mouth ulcers, swollen gums, lymph node pain in neck and throat pain. The events resulted in doctor or other healthcare professional office/clinic visits. Therapeutic measures were taken as a result of the events included treatment with unspecified steroids and antibiotics. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event persistent mouth ulcers, swollen gums, lymph node pain in neck, throat pain was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site felt itchy; Swollen to about the size of a quarter; the swelling is now about 4'" in diameter, fiery red, and still itchy; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 04Mar2021 at 16:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis multiple joint, spinal stenosis and allergy to nickel since an unknown date and knee replacement on an unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), vitamins and venlafaxine (MANUFACTURER UNKNOWN) on an unknown date ,for an unknown indication and unknown if ongoing.  On 12Mar2021 at 10:00, the patient felt injection site itchiness, and when examined, was swollen to about the size of a quarter. By the time the patient got home from work, it was also red. On 13Mar2021, in the morning, the swelling was about 4 inch in diameter, fiery red, and still itchy. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site felt itchy, swollen to about the size of a quarter and fiery red was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore left arm for 2 days; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date(at the age of 61-years-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history and concomitant medication was not reported. On an unknown date, the patient experienced sore left arm for 2 days. The clinical outcome of the event sore left arm for 2 days was recovered on unknown date.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Gout, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 58-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6201), at the age of 58, via an unspecified route of administration, in the left arm, on Mar 2, 2021, at 09:30, single dose, for COVID-19 immunisation. Medical history included diabetes and high blood pressure. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient received unknown medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 6, 2021, patient experienced gout symptoms in feet, wrist, elbows and knees. The event resulted in doctor or other healthcare professional office/clinic visit. On Mar 12, 2021, patient underwent rapid test, with result of negative. On Mar 12, 2021, patient underwent PCR test, with result of pending. Therapeutic measures for the event reported as pending. The outcome of gout symptoms in feet, wrist, elbows and knees: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity
Clinical narrative: Tasted a strong metallic taste; Arm hurt to move and couldnt use it for about 12 hour; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 09:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021, at 12:00 the patient reported she tasted a strong metallic taste and arm hurt to move and could not use it for about 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tasted a strong metallic taste and arm hurt to move and could not use it for about 12 hours was resolving at the time of the report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Arm pain; Arm pain and not able to lift arm after 2 weeks of getting vaccine; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 26Feb2021 at 13:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks of vaccination. On 26Feb2021 at 13:30, the patient experienced arm pain and not able to lift arm after 2 weeks of getting vaccine. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm pain and not able to lift arm after 2 weeks of getting vaccine was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Body temperature increased, Chills, Headache
Clinical narrative: Laying in bed sick, and the card is in the other room.,; Body wracking chills; Temperature 101.5 degrees; Headache; Body aches; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Mar2021 at 09:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Concomitant medications not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Feb2021 at 09:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 12Mar2021 at 20:00, the patient experienced body wracking chills, temperature 101.5 degrees, headache, body aches, weakness and was lying in bed sick. On the same day and same time, the patient underwent temperature test and the result was 101.5 degrees (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events body wracking chills, temperature 101.5 degrees, headache, body aches, weakness and lying in bed sick were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pain
Clinical narrative: Laying in bed sick, and the card is in the other room.,; Body wracking chills; Temperature 101.5 degrees; Headache; Body aches; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Mar2021 at 09:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Concomitant medications not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Feb2021 at 09:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 12Mar2021 at 20:00, the patient experienced body wracking chills, temperature 101.5 degrees, headache, body aches, weakness and was lying in bed sick. On the same day and same time, the patient underwent temperature test and the result was 101.5 degrees (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events body wracking chills, temperature 101.5 degrees, headache, body aches, weakness and lying in bed sick were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes left armpit; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 at 13:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 09Mar2021 at 12:00, the patient experienced swollen lymph nodes left armpit. The event did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes left armpit was not resolved at the time of the report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 23-years-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Mar2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Mar2021, the patient experienced arm soreness. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm soreness was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Parosmia, Taste disorder, Weight decreased
Clinical narrative: Taste buds have been altered; Arms of smell have been altered; Losing weight; Couldn't eat savory foods; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate/amfetamine sulfate/ dexamfetamine saccharate/ dexamfetamine sulfate (ADDERALL), buspirone hydrochloride (BUSPAR), levonorgestrel (MIRENA) and clonazepam (KLONOPIN); all from an unknown start date for an unknown indication and unknown if ongoing. On 01Mar2021, the patient's taste buds and arms of smell had been altered. Things that used to smell pleasant repulsed the patient. This happened after the 2nd dose of the vaccine. The patient lost weight and couldn't eat savory foods. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events taste buds have been altered, arms of smell have been altered, losing weight and couldn't eat savory foods were not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: 10 mins in very minor soreness in arm; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA156051) via an unspecified route of administration in the left arm on 12Mar2021 at 15:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021 at 15:15, the patient experienced 10 minutes in very minor soreness in arm. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Mar2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was unknown. The clinical outcome of the event 10 minutes in very minor soreness in arm was resolving at the time of the report.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Mild redness, itching and soreness at injection site ~9 days after injection; Mild redness, itching and soreness at injection site ~9 days after injection; Mild redness, itching and soreness at injection site ~9 days after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 02Mar2021 at 09:00(at the age of 34-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. On 11Mar2021, approximately 9 days after the injection, the patient experienced mild redness, itching and soreness at injection site. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild redness, itching and soreness at injection site was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: Right armpit starting hurting; Noticed lymph nodes swollen; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 28Feb2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies, high blood pressure, type 2 diabetic and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient received unspecified concomitant medications. The patient previously received cefuroxime axetil (CEFTIN) and experienced drug allergy. On 03Mar2021, a couple of days after the shot, the patient's right armpit started hurting and noticed lymph nodes swollen about a week later after the shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right armpit starting hurting and noticed lymph nodes swollen was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, SARS-CoV-2 test
Clinical narrative: Headache; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 10Mar2021 at 17:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient has no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 11Mar2021 at 18:00, the patient experienced headache, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 09Mar2021, the patient underwent SARS-CoV-2 test and the result was negative. The clinical outcome of the events headache, chills and fatigue was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Burning sensation, Decreased appetite, Freezing phenomenon, Injection site discomfort
Clinical narrative: Sunday-Tuesday pressure in abdomen,; loss of appetite,; wake up in middle of the night burning to the bones.; freezing to the bones at night; Friday and Saturday, pressure at injection site.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfa allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Mar2021, the patient experienced from friday and saturday, pressure at injection site.  On 07MAr2021, sunday to tuesday the patient experienced pressure in abdomen, loss of appetite, freezing to the bones at night and then wake up in middle of the night burning to the bones. As fast as it came on Sunday it left and felt completely normal on tuesday evening. Was unable to eat for 48 hours but when normal was not starving, normal appetite as if nothing happened. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pressure, pressure in abdomen, loss of appetite, freezing to the bones at night, burning to the bones were recovered on an unknown date in Mar2021 at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Swollen painful lymph node; Swollen painful lymph node; This is a spontaneous report from a contactable other healthcare professional, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via an unspecified route of administration in the left arm on 19Jan2021 at 12:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140) via an unspecified route of administration in the left arm on 29Dec2020 at 12:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 20Jan2021, the patient experienced swollen painful lymph node. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 10Mar2021, the patient underwent nasal swab (SARS-CoV-2 test) and the result was negative. The clinical outcome of the events swollen painful lymph node was resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza like illness, Pain
Clinical narrative: Chills; Body aches; Feel like flu; Tired; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 11Mar2021 at 15:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not received any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EI3247) via an unspecified route of administration in the left arm on 19Feb2021 at 15:10 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 12Mar2021 at 02:30 the patient experienced chills, body aches, felt like flu and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event chills was resolved on 13Mar2021 at 07:15. The clinical outcome of the events body aches, felt like flu and tired was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Nausea, Somnolence
Clinical narrative: Very drowsy; Light headache that lasted through the next afternoon; Light nausea; Dizziness; Fuzzy head feeling; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 10:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, graves disease and vascular problem. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid/calcium carbonate/calcium pantothenate/calcium phosphate/chromium/cyanocobalamin/folic acid/magnesium carbonate/magnesium hydroxide/manganese gluconate/nicotinic acid/potassium bicarbonate/potassium carbonate/potassium phosphate dibasic/pyridoxine hydrochloride/quercetin/riboflavin sodium phosphate/sodium bicarbonate/sodium phosphate/thiamine hydrochloride/thioctic acid/zinc ascorbate (EMERGEN C) and unspecified fiber supplements; both for unknown indication from an unknown date and unknown if ongoing. On 11Mar2021, the patient was great for the first hour. Then very drowsy, light headache that lasted through the next afternoon, light nausea, dizziness, fuzzy head feeling. Over the counter medications (unspecified) helped and all good now. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with over the counter medications acetylsalicylic acid/chlorphenamine maleate/phenylpropanolamine bitartrate (ALKA-SELTZER COLD) and paracetamol/acetylsalicylic acid/caffeine (EXCEDRIN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very drowsy and light headache that lasted through the next afternoon was resolved on 12Mar2021. The clinical outcome of the events light nausea, dizziness, fuzzy head feeling was resolved on an unknown date in Mar2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Red welt at injection site 8 days after receiving vaccine; It itched at first but now feels warm; It itched at first but now feels warm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 04Mar2021 at 14:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone propionate (FLONASE) and azelastine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 12Mar2021, the patient experienced red welt at injection site 8 days after receiving vaccine. It itched at first but now feels warm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red welt at injection site 8 days after receiving vaccine. It itched at first but now feels warm was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Short terms of Dizziness 2 days after 2nd dose; Spinning 2 days after 2nd dose; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 13:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic lymphocytic leukemia and COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient took concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 17Feb2021 at 13:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 12Mar2021, 2 days after vaccination at 18:45 the patient experienced short terms of dizziness and spinning. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events short terms of dizziness and spinning was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at injection site; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Mar2021 at 00:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included High Blood Pressure (HBP) and high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 13Mar2021 at 00:00, the patient experienced rash at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash at injection site was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Immediately after and again 5 days after "my" left hand is tingling a lot; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE ;Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and gold allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included citalopram hydrobromide (CELEXA) for unknown indication from an unknown date and unknown if ongoing. The patient previously received acetylsalicylic acid (ASPIRIN) and paracetamol (ACETAMINOPHEN), for unknown indication on an unknown date and experienced drug allergy. On an unknown date, the patient experienced immediately after and again 5 days after, the patient's left hand was tingling a lot. The patient had not heard that effect reported so she wanted to report it. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event immediately after and again 5 days after left hand is tingling a lot was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Tongue tingling; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GN6199) via an unspecified route of administration in the right arm on 12Mar2021 at 14:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic reaction to steroid medication in 2018 for sinus infection, various food allergies and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included calcium, colecalciferol (NATURES BOUNTY CALCIUM; VITAMIN D3), taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received doxycycline (MANUFACTURER UNKNOWN) and experienced drug allergy. On 12Mar2021 at 15:05, approximately 20 minutes after the vaccination, the patient experienced tongue tingling. The patient was not worried and just wanted to report, the event only lasted a few minutes. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tongue tingling was recovered on 12Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: Sore arm; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199, Expiration date: an unknown date in Jun2021) via an unspecified route of administration in the left arm on 05Mar2021 at 16:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 05Mar2021, the patient experienced sore arm, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, chills and fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Redness at site of injection; swelling site of injection; itching at site of injection; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 08:15 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus, Lyme disease, Hashimoto's disease, factor v Leiden and penicillin allergy. The patient previously took erythromycin (MANUFACTURER UNKNOWN), levofloxacin (LEVAQUIN) and hydroxychloroquine sulfate (PLAQUENIL) all on an unspecified date, for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included losartan (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID) and lorazepam (MANUFACTURER UNKNOWN); all were taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 18Feb2021 at 13:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. On 12Mar2021 at 18:00, the patient experienced redness, swelling and itching at site of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events redness, swelling and itching at site of injection was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Fore and middle finger knuckles swelled huge; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Feb2021 at 12:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included LOSARTIN and ATORVASTIN, both for an unknown indication from an unknown date and unknown if ongoing. On 19Feb2021 at 16:00, the patient experienced fore and middle finger knuckles swelled huge. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fore and middle finger knuckles swelled huge was resolving at the time of this report.    No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity
Clinical narrative: Severe upper arm pain. Unable to raise arm or lift anything with left arm.; Sudden severe & profuse diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 15:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma, premature ventricular contractions, partial right bundle branch blockage and osteoarthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL); both for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 21:00, about 6 hours after shot, the patient experienced severe upper arm pain, unable to raise arm or lift anything with left arm and sudden severe and profuse diarrhea and unlike anything she had ever experienced. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events experienced severe upper arm pain, unable to raise arm or lift anything with left arm and sudden severe and profuse diarrhea was recovered on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.